By: Laymah E. Kollie
The Amplifying Rights Network (ARN) has raised serious concerns over proposed and ongoing restrictions on the use and sale of Misoprostol in Liberia, warning that such measures could significantly worsen maternal health outcomes and endanger the lives of women and girls.
Misoprostol, also known as Cytotec, is widely used for medical abortions, particularly when combined with Mifepristone.
Beyond abortion care, the drug plays a critical role in managing miscarriages, inducing labor, treating postpartum hemorrhage, and preventing stomach ulcers caused by NSAIDs.
On April 3, 2026, the Ministry of Health Liberia raised alarm over the unregulated sale and use of Misoprostol across the country.
In response, the Ministry, in collaboration with the Liberia Medicines and Health Products Regulatory Authority, Liberia Pharmacy Board, and Liberia Medical and Dental Council, announced stricter controls.
These include requiring a valid prescription from a licensed physician and limiting dispensing to licensed pharmacists operating within approved facilities.
The move has triggered mixed reactions nationwide. However, ARN, in a position statement released Monday, described Misoprostol as a life-saving medication essential to reducing maternal deaths.
The group warned that tightening access could reverse fragile gains made in tackling Liberia’s high maternal mortality rate, estimated at over 1,000 deaths per 100,000 live births.
According to ARN, additional restrictions, especially making the drug strictly prescription-based, could create dangerous delays in accessing urgent care, particularly in rural communities with limited healthcare infrastructure.
“Access to life-saving interventions is not optional; it is urgent,” the statement emphasized, noting that regulatory barriers often translate into denied or delayed care for vulnerable populations.
The network further highlighted Liberia’s restrictive abortion laws, arguing they contribute to unsafe practices.
With an estimated 38,000 abortions occurring annually, many outside formal health systems, unsafe procedures account for roughly 10 to 15 percent of maternal deaths.
“This is a critical lesson: restriction does not stop need, it only makes outcomes more dangerous,” ARN stated.
The group warned that tighter controls would disproportionately impact rural women, young people, and low-income families who already face systemic barriers to healthcare access.
While wealthier urban women may still find safe options, others risk turning to unsafe alternatives, increasing complications such as sepsis, hemorrhage, and infertility.
ARN is now urging the Liberian government to adopt evidence-based policies that expand safe, community-level access to reproductive health services.
It also called for increased public education and greater support for midwives and community health workers.
“Restrictive policies on reproductive health drugs do not protect women; they put them at risk,” the statement concluded. “Protect access, protect health, and protect lives.”
